| Affiliation: | 1. Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain;;2. Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;;3. Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan;;4. Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden;;5. ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain. |
